Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to rise 25.00% to -20 cents per share on May 09

Q1'25

Est.

$-0.20

Q4'24

Beat

by $0.09

Q3'24

Missed

by $0.08

Q2'24

Missed

by $0.24

Q1'24

Missed

by $0.06

The last earnings report on March 28 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 2.39M shares outstanding, the current market capitalization sits at 238.11M.

View a ticker or compare two or three

Compare

HUMA